VIEMED HEALTHCARE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
VIEMED HEALTHCARE, INC. (VMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 764.00K shares, a 13.08% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | 0.00 shares 10-Q · filed 2026-08-03 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-03 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-05 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-05 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-04 | 0.00 shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-05 | 0.00 shares 10-Q · filed 2025-11-05 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 0.00 shares 10-Q · filed 2025-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-04 | 0.00 shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-06 | 0.00 shares 10-Q · filed 2024-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 0.00 shares 10-Q · filed 2024-08-07 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-06 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-04 | 0.00 shares 10-K · filed 2026-03-04 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-01 | 0.00 shares 10-Q · filed 2023-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 0.00 shares 10-Q · filed 2023-08-09 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-10 | 52.00K shares derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-10 | 52.00K shares derived: sum of 3 quarters · filed 2025-03-10 | 81.00K shares derived: sum of 4 quarters · filed 2025-03-10 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | 52.00K shares derived: sum of 2 quarters · filed 2025-03-10 | 81.00K shares derived: sum of 3 quarters · filed 2025-03-10 | 764.00K shares 10-K · filed 2025-03-10 |
| 2022-09-30 | 52.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 81.00K shares derived: sum of 2 quarters · filed 2022-11-01 | 764.00K shares 10-Q · filed 2022-11-01 | 814.00K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | 29.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 712.00K shares 10-Q · filed 2022-08-02 | 762.00K shares derived: sum of 3 quarters · filed 2023-03-02 | 762.00K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | 683.00K shares 10-Q · filed 2022-05-03 | 733.00K shares derived: sum of 2 quarters · filed 2023-03-02 | 733.00K shares derived: sum of 3 quarters · filed 2023-03-02 | 756.00K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 50.00K shares derived: sum of 2 quarters · filed 2023-03-02 | 73.00K shares derived: sum of 3 quarters · filed 2023-03-02 | 879.00K shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 23.00K shares derived: sum of 2 quarters · filed 2021-11-02 | 829.00K shares 10-Q · filed 2021-11-02 | 865.00K shares derived: sum of 4 quarters · filed 2022-03-07 |
| 2021-06-30 | 23.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 829.00K shares 10-Q · filed 2021-08-03 | 865.00K shares derived: sum of 3 quarters · filed 2022-03-07 | 954.00K shares derived: sum of 4 quarters · filed 2022-03-07 |
| 2021-03-31 | 806.00K shares 10-Q · filed 2021-05-03 | 842.00K shares derived: sum of 2 quarters · filed 2022-03-07 | 931.00K shares derived: sum of 3 quarters · filed 2022-03-07 | 931.00K shares derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-12-31 | 36.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | 125.00K shares derived: sum of 2 quarters · filed 2022-03-07 | 125.00K shares derived: sum of 3 quarters · filed 2022-03-07 | 1.09M shares 10-K · filed 2022-03-07 |
| 2020-09-30 | 89.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 89.00K shares derived: sum of 2 quarters · filed 2020-11-04 | 1.05M shares 10-Q · filed 2020-11-04 | 1.09M shares derived: sum of 4 quarters · filed 2021-03-03 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 964.00K shares 10-Q · filed 2020-08-04 | 997.00K shares derived: sum of 3 quarters · filed 2021-03-03 | 997.00K shares derived: sum of 4 quarters · filed 2021-03-03 |
| 2020-03-31 | 964.00K shares 10-Q · filed 2020-05-05 | 997.00K shares derived: sum of 2 quarters · filed 2021-03-03 | 997.00K shares derived: sum of 3 quarters · filed 2021-03-03 | |
| 2019-12-31 | 33.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | 33.00K shares derived: sum of 2 quarters · filed 2021-03-03 | 1.27M shares 10-K · filed 2021-03-03 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 1.24M shares 10-Q · filed 2019-11-05 | ||
| 2019-06-30 | 1.24M shares 10-Q · filed 2019-08-09 | |||
| 2018-12-31 | 696.00K shares 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |